BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23767959)

  • 21. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling.
    Zhang C; Wendel AA; Keogh MR; Harris TE; Chen J; Coleman RA
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1667-72. PubMed ID: 22307628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver.
    Wang B; Zhang H; Luan Z; Xu H; Wei Y; Zhao X; Xing M; Huo X; Zhang J; Su W; Guan Y; Zhang X
    Exp Cell Res; 2020 May; 390(1):111949. PubMed ID: 32145254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor α (FXRα) in Stabilizing the Homodimerization of the Receptor.
    Xu X; Xu X; Liu P; Zhu ZY; Chen J; Fu HA; Chen LL; Hu LH; Shen X
    J Biol Chem; 2015 Aug; 290(32):19888-99. PubMed ID: 26100621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional Regulation of Human UDP-Glucuronosyltransferase 2B10 by Farnesoid X Receptor in Human Hepatoma HepG2 Cells.
    Lu D; Wang S; Xie Q; Guo L; Wu B
    Mol Pharm; 2017 Sep; 14(9):2899-2907. PubMed ID: 28267333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
    Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
    J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
    Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
    J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
    Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
    J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.
    Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD
    J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.
    Xin XM; Zhong MX; Yang GL; Peng Y; Zhang YL; Zhu W
    World J Gastroenterol; 2014 Nov; 20(42):15727-35. PubMed ID: 25400456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Farnesoid X Receptor Activation Impairs Liver Progenitor Cell-Mediated Liver Regeneration via the PTEN-PI3K-AKT-mTOR Axis in Zebrafish.
    Jung K; Kim M; So J; Lee SH; Ko S; Shin D
    Hepatology; 2021 Jul; 74(1):397-410. PubMed ID: 33314176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Farnesoid X receptor represses hepatic lipase gene expression.
    Sirvent A; Verhoeven AJ; Jansen H; Kosykh V; Darteil RJ; Hum DW; Fruchart JC; Staels B
    J Lipid Res; 2004 Nov; 45(11):2110-5. PubMed ID: 15342685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycerol-3-phosphate acyltransferase-4-deficient mice are protected from diet-induced insulin resistance by the enhanced association of mTOR and rictor.
    Zhang C; Cooper DE; Grevengoed TJ; Li LO; Klett EL; Eaton JM; Harris TE; Coleman RA
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E305-15. PubMed ID: 24939733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.
    Dwivedi SK; Singh N; Kumari R; Mishra JS; Tripathi S; Banerjee P; Shah P; Kukshal V; Tyagi AM; Gaikwad AN; Chaturvedi RK; Mishra DP; Trivedi AK; Sanyal S; Chattopadhyay N; Ramachandran R; Siddiqi MI; Bandyopadhyay A; Arora A; Lundåsen T; Anakk SP; Moore DD; Sanyal S
    Mol Endocrinol; 2011 Jun; 25(6):922-32. PubMed ID: 21493670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid.
    Avila-Flores A; Santos T; Rincón E; Mérida I
    J Biol Chem; 2005 Mar; 280(11):10091-9. PubMed ID: 15632115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of carbohydrate metabolism by the farnesoid X receptor.
    Stayrook KR; Bramlett KS; Savkur RS; Ficorilli J; Cook T; Christe ME; Michael LF; Burris TP
    Endocrinology; 2005 Mar; 146(3):984-91. PubMed ID: 15564327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity.
    Gineste R; Sirvent A; Paumelle R; Helleboid S; Aquilina A; Darteil R; Hum DW; Fruchart JC; Staels B
    Mol Endocrinol; 2008 Nov; 22(11):2433-47. PubMed ID: 18755856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.